Immunotherapy Flashcards
Cyclosporine action
Inhibits production of IL-2 by T cells
Cyclosporine use
Transplants and immune diseases
Cyclosporine mechanisms
Forms complex with cyclophilin + serine/threonine phosphatase calcineurin
—> disrupts phosphorylation of regulatory proteins —> NFATs —> don’t translocate to nucleus —> no IL-2 transcription
IL-2 function
Induce T cell mitogenesis
Tacrolimus (FK506) mechanism
Forms complex with FKBP —> inhibits calcineurin
Sirolimus mechanism
Binds to FKBP12 —> mTOR complex 1
—> inhibits mTOR pathway = inhibits IL-2 response
What importantly distinguished sirolimus from calcineurin inhibitors?
It has less renal toxicity
What is sirolimus used for? (5)
SLE
Sjörgen
RA
Psoriasis
Genetic
Neoplasic - Kaposi
Antimetabolite medications
Methotrexate
Azathioprine
Mechanisms of methotrexate
Folate antagonism prevents DNA synthesis
—> less cell proliferation (transient)
Inhibits spermine and spermidine production
—> inhibits S-adenosylmethione = no toxic s&s
Inhibits transmethylation
—> impair monocyte and lymphocyte function & ROS
Adenosine release
—> AICAR in tissues inhibits catabolism of adenosine
—> more adenosine = less neutrophil and infl.
Caffeine’s role with methotrexate
Inhibits release of adenosine
Decreases its effectiveness in RA BUT is protective vs cirrhosis
What are antimetabolites used for?
RA
IBD
Transplants
Azathioprine mechanism
Unclear
Purine analogue that interferes in DNA and RNA
Inhibits B and T cell proliferation, suppresses NK
Alters response to chemoattractants and IL-6 production
Which Fc receptor is inhibitory?
FcRIIB
Naming antibodies
-mab = monoclonal
Xi = chimeric while u = human
Li = immune system
Ex. Rit-u-xi-mab
Rituximab target and diseases
CD20
RA, ITP, TTP, MS, AIHA, NHL, CLL
Alemtuzumab target and diseases
CD52
T, Treg, B, MQ, NK, neutrophils
CLL, MS
Brentuximab-vedotin target and diseases
CD30 with auristatin E
T, B, RS cells
Hodgkin lymphoma